Epigenetics Diagnostics Market
According to Intent Market Research, the Epigenetics Diagnostics Market is expected to grow from USD 2.3 billion in 2023 at a CAGR of 13.9% to touch USD 5.8 billion by 2030. The Epigenetics Diagnostics Market is dominated by key players such as, Bio-Rad Laboratories, Agilent, Merck KGaA, Thermo Fisher Scientific, and Qiagen.